香港股市 已收市

Ortin Laboratories Limited (ORTINLAB.NS)

NSE - NSE 即時價格。貨幣為 INR。
加入追蹤清單
19.83-0.57 (-2.79%)
收市:03:29PM IST

Ortin Laboratories Limited

D. No. 1-8-B4, F3 HIG
Ground Floor Block-4, Street no. 3 Baghlingampally
Hyderabad 500044
India
91 40 2756 2055
https://www.ortinlabsindia.com

版塊Healthcare
行業Drug Manufacturers - Specialty & Generic
全職員工

高階主管

名稱頭銜支付行使價出生年份
Mr. Sanka Murali Krishna MurthyCEO & MD1959
Mr. Sanka Srinivasa KumarCFO & Whole Time Director1965
Ms. Divya PurswaniCompany Secretary & Compliance Officer
截止 為止計算的金額,現金賠償則計算至上一個財政年度末止。薪資是指薪俸、獎金等。已行使價是指財政年度期間已行使的期權價值。貨幣為 INR。

描述

Ortin Laboratories Limited engages in the manufacture and trading of pharmaceuticals, drugs, and intermediates in India. The company offers various pharmaceutical formulations of tablets, capsules, syrups, and dry powders. It provides formulations, such as anti-diabetics, anti allergics, sedatives and tranquilisers, anti helmenthetics, analgesics and antipyretics, anti-biotics-quinolones, anti-biotic-pencillins, antifungal, cephalosporins, and macrolides; and anti-anginal and cardio vascular, and antifungal products. Its formulations also include chemo therapeutics, antacids and anti ulcerants, anti spasmodics, calcium and iron preparations, anti-arthritic drugs, protein supplements, enzymes, and vitamins, as well as psychiatry, appetizer, gynaec, and anti-retroviral products. In addition, the company offers active pharmaceutical ingredient (API) intermediates, including anti retro viral, anti-diabetics, analgesics and antipyretics, anti-biotics, antifungal, antacids and anti ulcerants, and anti malarials; and manufactures fine chemicals, and grignard and alkali metal products. Further, the company provides services in the areas of process development, process and product characterization, analytical research and development, and assay development; and diagnostic services comprising development of rapid flow kits, assays, and reagents. Additionally, it undertakes long-term contracts for manufacturing intermediates and developing new APIs; and operates as a merchant exporter of pharmaceutical finished formulations. Ortin Laboratories Limited was incorporated in 1986 and is headquartered in Hyderabad, India.

公司管治

截至 無 止,Ortin Laboratories Limited 的 ISS 管治質素評分為 無。 Pillar 分數正在審核中:無;董事會:無;股東權利:無;現金賠償:無。

企業管治評分的資料提供: Institutional Shareholder Services (ISS). 評分將以 1 至 10 分顯示 (與指數或地區相關)。1 分表示較低的管治風險,而 10 分表示較高的管治風險。